Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia : results from the 24-month follow-up of the BELA trial

Brümmendorf, Tim Henrik; Gambacorti-Passerini, Carlo; Pavlov, Dmitri; Duvillié, Ladan; Guilhot, Francois; Countouriotis, Athena M.; Gogat, Karïn; Cortes, Jorge E.; de Souza, Cármino Antonio

doi:PREV201500096511

Mehr Informationen
Referenzen (0)
Diskussion (0)
Dateien

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia : results from the 24-month follow-up of the BELA trial - RWTH-2015-05207

Ähnliche Datensätze

h1

h2

h3

h4

h5

h6

RWTH

Kontakt

RWTH Publications

Allgemeines